|
Lenz Therapeutics Inc (LENZ) |
|
Price: $24.8400
$-0.04
-0.161%
|
Day's High:
| $24.98
| Week Perf:
| -6.93 %
|
Day's Low: |
$ 24.01 |
30 Day Perf: |
7.07 % |
Volume (M): |
104 |
52 Wk High: |
$ 38.93 |
Volume (M$): |
$ 2,583 |
52 Wk Avg: |
$23.85 |
Open: |
$24.45 |
52 Wk Low: |
$14.42 |
|
|
Market Capitalization (Millions $) |
675 |
Shares
Outstanding (Millions) |
27 |
Employees |
51 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-161 |
Cash Flow (TTM) (Millions $) |
143 |
Capital Exp. (TTM) (Millions $) |
11 |
Lenz Therapeutics Inc
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Clinical Study
Published Mon, Aug 12 2024 12:00 PM UTC
In a significant milestone for the field of ophthalmology, SAN DIEGO-based LENZ Therapeutics, Inc. (Nasdaq: LENZ), has announced a major development that promises to bring transformative change to millions. As of August 12, 2024, LENZ Therapeutics, a late clinical-stage biopharmaceutical company, submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration...
|
Financing Agreement
Published Mon, Jul 15 2024 12:01 PM UTC
LENZ Therapeutics Enhances Tangible Leverage Ratio and Secures $30 Million Investment from Ridgeback Capital SAN DIEGO, July 15, 2024 - LENZ Therapeutics, Inc. (Nasdaq: LENZ or LENZ or the Company), a late clinical-stage biopharmaceutical company, has recently made significant strides towards improving its financial position. The company announced today that it has enter...
|
Per Share |
Current |
Earnings (TTM) |
-4.95 $ |
Revenues (TTM) |
-
|
Cash Flow (TTM) |
5.24 $ |
Cash |
7.99 $
|
Book Value |
7.92 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-4.95 $
|
Revenues (TTM) |
- |
Cash Flow (TTM) |
5.24 $ |
Cash |
7.99 $
|
Book Value |
7.92 $ |
Dividend (TTM) |
0 $ |
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com